ASTX-029
Products
Description
ASTX-029 is an orally bioavailable inhibitor of the extracellular signal-regulated kinases (ERK) 1 and 2, with potential antineoplastic activity. ASTX-029 inhibits ERK-dependent tumor cell proliferation and survival.
Specifications
| Manufacturer Cat# | S0872 |
|---|---|
| Target | ERK |